TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL) ...

AFP had a significant presence at the 2024 International Journalism Festival in Perugia, Italy, with several representatives scheduled to speak during the event from 17th to 21st April. AFP Global ...

Suzano Ventures, the corporate venture capital arm of Suzano, the world’s largest market pulp producer, has made a strategic investment into the Canadian materials science startup, Bioform ...

Incyte (Nasdaq:INCY) and Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuro-immune disorders, ...

At the invitation of the Japanese Parliamentary Committee of the World Federation, the founding Vice Chancellor of O.P.

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support ...

Total turnover was stable (+0,1%), at 320.1 million euros. Operating expenses were 297 million euros, a decrease of 0.4 percent (- 1.2 million euros) compared to 2022 at comparable exchange rates.

Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10 th consecutive Leaders Quadrant within the report, a complimentary copy of which can be ...

Anticipating Gateway: Showdown playtest, Farcana’s website and game platform have a new look, offering a streamlined and ...

Helium Gas Atomization is Best for Powder Atomization: Research indicates that, from an energy perspective, helium gas ...

Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark ...

People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one ...